🕵️ ELI Lilly and Company ($LLY)
SEC insider & ownership activity, last 12 months · CIK 59478 · every row links its SEC filing
Over the last 12 months insiders sold $79.4B against $4.5M of open-market buying. Lilly Endowment, Inc. sold $79.4B through a program of 14 sale notices averaging $305.2M (Sep–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
8 buyers, $4.5M (9 lots) · 3 sellers, $79.4B (374 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Lilly Endowment, Inc. | 0 | – | 370 | $79.4B | May 6, 2026 |
| Yuffa Ilya | 0 | – | 2 | $3.7M | Jun 10, 2026 |
| Donald Zakrowski | 0 | – | 2 | $1.7M | Nov 13, 2025 |
| David A. Ricks | 1 | $1.1M | 0 | – | Aug 12, 2025 |
| Fyrwald J Erik | 2 | $1.0M | 0 | – | Aug 12, 2025 |
| Van Naarden Jacob | 1 | $647K | 0 | – | Aug 13, 2025 |
| Skovronsky Daniel | 1 | $634K | 0 | – | Aug 12, 2025 |
| Alvarez Ralph | 1 | $500K | 0 | – | Aug 13, 2025 |
| Montarce Lucas | 1 | $495K | 0 | – | Aug 15, 2025 |
| Jackson Jamere | 1 | $128K | 0 | – | Aug 8, 2025 |
| Sulzberger Gabrielle | 1 | $75K | 0 | – | Aug 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Lilly Endowment, Inc. | 9.6% | 13G | Jul 23, 2026 | filing ↗ | |
| Vanguard Capital Management | 6.5% | 13G | May 1, 2026 | filing ↗ | |
| The PNC Financial Services Group, Inc. | 5.4% | 13G | Feb 7, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Lilly Endowment, Inc. | $372.0M | Jul 7, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $343.9M | Jun 26, 2026 | filing ↗ |
| Yuffa Ilya | $2.9M | Jun 10, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $335.7M | May 28, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $312.5M | May 22, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $311.5M | May 20, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $296.7M | May 6, 2026 | filing ↗ |
| Lilly Endowment, Inc. | $322.9M | Dec 23, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $323.2M | Nov 24, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $319.3M | Nov 19, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $300.2M | Nov 13, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $301.5M | Nov 12, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $277.3M | Nov 10, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $197.2M | Nov 4, 2025 | filing ↗ |
| Lilly Endowment, Inc. | $258.9M | Nov 3, 2025 | filing ↗ |
| Lilly Endowment Inc | $260.9M | Oct 10, 2025 | filing ↗ |
| Lilly Endowment Inc | $252.0M | Oct 6, 2025 | filing ↗ |
| Lilly Endowment Inc | $251.8M | Oct 2, 2025 | filing ↗ |
| Lilly Endowment Inc | $225.1M | Oct 1, 2025 | filing ↗ |
| Lilly Endowment Inc | $228.0M | Sep 18, 2025 | filing ↗ |
| Donald Zakrowski | $1.5M | Aug 28, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 4, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 18, 2025 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Other events (8.01) | Aug 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |